All Things Mobile Analytic Inc. (ATMH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
All Things Mobile Analytic Inc. (ATMH) trades at $0.0593 with AI Score 39/100 (Grade D). All Things Mobile Analytic Inc. Market cap: $32.2M, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for ATMH: ATMH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ATMH against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ATMH: 2/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
All Things Mobile Analytic Inc. (ATMH) Financial Services Profile
All Things Mobile Analytic Inc. (ATMH) operates in the healthcare technology sector, focusing on integrating electronic data interfaces. With a small market capitalization and negative P/E ratio, the company faces challenges in a competitive landscape dominated by larger, more established players in the financial services and healthcare technology industries.
What Is the Investment Thesis for ATMH?
Investing in All Things Mobile Analytic Inc. (ATMH) presents a high-risk, high-reward scenario. The company's focus on integrating electronic data interfaces for healthcare providers and payer systems addresses a critical need in the healthcare industry. However, ATMH's small market capitalization of $32.2M, coupled with a negative P/E ratio of -69.67 and a negative gross margin of -31.9%, indicates significant financial challenges. Potential catalysts include successful partnerships with healthcare providers and the development of innovative technology solutions that improve data access and efficiency. The company's low beta of 0.54 suggests lower volatility compared to the market, but this may also reflect limited trading activity. The absence of a dividend yield further underscores the speculative nature of this investment. Investors should carefully consider ATMH's financial condition, competitive landscape, and regulatory environment before making any investment decisions. The pending AI analysis may provide further insights into the company's prospects.
Based on FMP financials and quantitative analysis
ATMH Key Highlights
Market capitalization of $32.2M indicates a micro-cap company with limited resources and higher risk.
- Negative P/E ratio of -69.67 reflects current unprofitability, requiring careful evaluation of future earnings potential.
- Profit margin of 8.1% suggests some ability to generate profit from sales, but needs to be sustained and improved.
- Negative gross margin of -31.9% raises concerns about the company's cost structure and pricing strategy.
- Beta of 0.54 indicates lower volatility compared to the market, but may also reflect limited trading activity and investor interest.
Who Are ATMH's Competitors?
ATMH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ADCV ADCapital US Inc. | $0.07 | +0.00% | $26.7M | 44 |
| AEAE AltEnergy Acquisition Corp. | $12.01 | +0.00% | $72.2M | 47 |
| AOGO Arogo Capital Acquisition Corp. | $2.00 | +0.00% | $5.27M | 44 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ATMH's Key Strengths?
Focus on integrating electronic data interfaces for healthcare providers.
- Expertise in mobile analytics and healthcare technology.
- Potential for growth in the expanding healthcare IT market.
What Are ATMH's Weaknesses?
Small market capitalization and limited financial resources.
- Negative P/E ratio and negative gross margin.
- Dependence on a niche segment of the healthcare IT market.
What Could Drive ATMH Stock Higher?
Potential partnerships with healthcare providers to expand market reach.
- Development of innovative technology solutions to improve data access and efficiency.
- Release of AI analysis providing further insights into the company's prospects.
What Are the Key Risks for ATMH?
Negative return on equity (-36.5%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Limited financial resources and negative profitability.
- Intense competition from larger technology and healthcare companies.
- Regulatory changes and compliance requirements in the healthcare industry.
- Limited liquidity and wide bid-ask spreads due to OTC Other listing.
What Are the Growth Opportunities for ATMH?
- Partnerships with Healthcare Providers: ATMH can expand its market reach by forming strategic alliances with healthcare providers and payer systems. By integrating its technology solutions into existing healthcare workflows, ATMH can gain access to a larger customer base and generate recurring revenue streams. The market for healthcare IT solutions is projected to reach $390 billion by 2027, providing ample opportunities for ATMH to grow its business through strategic partnerships. Timeline: Ongoing.
- Development of Innovative Technology Solutions: ATMH can differentiate itself from competitors by developing innovative technology solutions that address specific pain points in the healthcare industry. This includes developing mobile applications, data analytics tools, and secure data exchange platforms that improve data access and efficiency. The market for healthcare analytics is expected to reach $67.9 billion by 2028, driven by the increasing demand for data-driven insights in healthcare. Timeline: Ongoing.
- Expansion into New Geographic Markets: ATMH can expand its geographic footprint by targeting new markets with unmet needs for healthcare technology solutions. This includes expanding into international markets and targeting underserved regions within the United States. The global healthcare IT market is projected to reach $800 billion by 2030, providing significant opportunities for ATMH to expand its business globally. Timeline: 2027-2030.
- Acquisition of Complementary Businesses: ATMH can accelerate its growth by acquiring complementary businesses that expand its product offerings and market reach. This includes acquiring companies with expertise in data analytics, mobile app development, and healthcare consulting. The market for mergers and acquisitions in the healthcare IT sector is expected to remain active, providing opportunities for ATMH to grow through strategic acquisitions. Timeline: 2028-2030.
- Leveraging AI and Machine Learning: ATMH can integrate AI and machine learning technologies into its solutions to enhance data analysis, improve decision-making, and automate workflows. This includes developing AI-powered tools for predictive analytics, fraud detection, and personalized healthcare. The market for AI in healthcare is projected to reach $45.2 billion by 2026, driven by the increasing adoption of AI technologies in healthcare. Timeline: Ongoing.
What Are ATMH's Competitive Advantages?
- Proprietary technology for integrating electronic data interfaces.
- Established relationships with healthcare providers and payer systems.
- Expertise in healthcare data analytics and mobile app development.
What Does ATMH Do?
All Things Mobile Analytic Inc., formerly known as Toron, Inc., rebranded in August 2020 to reflect its focus on mobile analytics within the healthcare sector. Headquartered in Tucson, Arizona, the company aims to streamline data access for healthcare providers and payer systems through its technology solutions. ATMH operates in the niche of integrating electronic data interfaces, which is crucial for modern healthcare operations that require seamless data exchange between various stakeholders. The company's evolution from Toron, Inc. to All Things Mobile Analytic Inc. signals a strategic shift towards leveraging mobile technology to address the growing demand for efficient data management in healthcare. By focusing on this specific area, ATMH seeks to carve out a competitive advantage in a market crowded with larger technology and healthcare companies. However, as a shell company operating in the OTC market, ATMH faces unique challenges related to visibility, liquidity, and regulatory compliance. Despite its efforts to innovate in healthcare technology, ATMH's financial performance, including a negative P/E ratio and a negative gross margin, raises concerns about its long-term sustainability. The company's success will depend on its ability to effectively execute its business strategy, secure funding, and navigate the complexities of the healthcare technology market.
What Products and Services Does ATMH Offer?
- Integrates access to electronic data interfaces for healthcare providers.
- Provides technology solutions for payer systems.
- Focuses on mobile analytics within the healthcare sector.
- Streamlines data access for efficient healthcare operations.
- Develops mobile applications for healthcare data management.
- Offers data analytics tools for healthcare insights.
- Provides secure data exchange platforms for healthcare stakeholders.
How Does ATMH Make Money?
- Provides technology solutions to healthcare providers and payer systems.
- Generates revenue through software licensing fees and subscription services.
- Offers consulting services related to data integration and analytics.
What Industry Does ATMH Operate In?
All Things Mobile Analytic Inc. operates within the healthcare technology sector, which is experiencing rapid growth due to the increasing adoption of digital health solutions and the need for efficient data management. The market is characterized by intense competition, with established players and emerging startups vying for market share. ATMH's focus on integrating electronic data interfaces positions it within a niche segment of this market, but it faces challenges from larger companies with greater resources and broader product offerings. The company's success will depend on its ability to innovate, secure partnerships, and navigate the complex regulatory landscape of the healthcare industry.
Who Are ATMH's Key Customers?
- Healthcare providers (hospitals, clinics, physician practices).
- Payer systems (insurance companies, government agencies).
- Healthcare technology companies.
Financial Health
All Things Mobile Analytic Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 2.33 places it in the grey zone, a middle ground that warrants monitoring.
Key Financial Metrics
Return on equity for All Things Mobile Analytic Inc. stands at -36.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -5.9%, showing how much profit it generates from its asset base. Its free cash flow yield is 5.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.95 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -11.2%, the inverse of the P/E and a quick read on earnings relative to price.
All Things Mobile Analytic Inc. (ATMH) Valuation Context
Valued at $32.2M, ATMH is classified as a micro-cap stock. Relative to its peer group, ATMH's quantitative score of 39/100 is below the peer average of 51/100.
ATMH Revenue & Earnings Trend
In Q1 2026, ATMH generated $1.4M in top-line revenue, marking a sequential decrease of 95.7%. The company recorded a net loss of $440K, with diluted EPS of $-0.01. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Financial Services. Across the four most recent quarters, ATMH averaged $-0.00 in diluted EPS.
Company Profile
All Things Mobile Analytic Inc. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Tucson, US. The company is led by CEO Massimo Meneghello. ATMH has traded publicly since 2013.
ATMH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Focus on integrating electronic data interfaces for healthcare providers.
- Expertise in mobile analytics and healthcare technology.
- Potential for growth in the expanding healthcare IT market.
- Ongoing: Potential partnerships with healthcare providers to expand market reach.
Bear Case
- Small market capitalization and limited financial resources.
- Negative P/E ratio and negative gross margin.
- Dependence on a niche segment of the healthcare IT market.
- Ongoing: Limited financial resources and negative profitability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1M | -$439,570 | -$0.01 |
| Q4 2025 | $33M | -$6M | -$0.01 |
| Q3 2025 | $5M | $642,124 | $0.0012 |
| Q2 2025 | $13M | $3M | $0.01 |
Based on FMP financials and quantitative analysis
ATMH Latest News
No recent news available for ATMH.
ATMH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ATMH.
Price Targets
Wall Street price target analysis for ATMH.
ATMH MoonshotScore
What does this score mean?
The MoonshotScore rates ATMH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Shell CompaniesLeadership: Massimo Meneghello
CEO
Massimo Meneghello serves as the CEO of All Things Mobile Analytic Inc. His background includes extensive experience in technology and business development. Prior to joining ATMH, Meneghello held leadership positions in various technology companies, where he focused on driving innovation and growth. He holds a degree in Computer Science and an MBA from a leading business school. Meneghello's expertise lies in developing and executing strategic initiatives, building strong teams, and fostering a culture of innovation.
Track Record: Since assuming the role of CEO, Massimo Meneghello has focused on repositioning ATMH as a leading provider of healthcare technology solutions. Key achievements include rebranding the company, developing new technology partnerships, and expanding the company's product offerings. Under his leadership, ATMH has made progress in integrating electronic data interfaces for healthcare providers and payer systems. However, the company's financial performance remains a challenge.
ATMH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that All Things Mobile Analytic Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume, minimal disclosure, and higher risks compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires careful due diligence and an understanding of the associated risks.
- OTC Tier: OTC Other
- Limited liquidity and wide bid-ask spreads.
- Lack of transparency and minimal disclosure requirements.
- Higher risk of fraud and manipulation.
- Potential for delisting and loss of investment.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review the company's financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the company's management team and track record.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings against the company.
- Company has a registered business address and contact information.
- Company has a functional website with information about its products and services.
- Company has a management team with relevant experience.
- Company has a clear business plan and strategy.
- Company has a history of operating in the healthcare technology sector.
ATMH Financial Services Stock FAQ
What does the AI Score mean for ATMH?
ATMH holds an AI Score of 39/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. All Things Mobile Analytic Inc. is a healthcare technology company focused on integrating access to electronic data interfaces for healthcare providers and payer systems. The company, formerly …
What does All Things Mobile Analytic Inc. do?
All Things Mobile Analytic Inc. operates as a healthcare technology company focused on integrating access to electronic data interfaces for healthcare providers and payer systems. The company's core business involves developing and deploying technology solutions that streamline data exchange and improve efficiency in healthcare operations.
What do analysts say about ATMH stock?
As of 2026-03-17, there is limited analyst coverage of All Things Mobile Analytic Inc. (ATMH) due to its small market capitalization and OTC listing. The absence of analyst ratings and price targets makes it difficult to assess the stock's valuation and growth potential.
What are the main risks for ATMH?
Investing in All Things Mobile Analytic Inc. (ATMH) involves several significant risks. The company's small market capitalization and negative profitability raise concerns about its financial sustainability. ATMH operates in a highly competitive industry, facing challenges from larger technology and healthcare companies with greater resources.
What are the key factors to evaluate for ATMH?
All Things Mobile Analytic Inc. (ATMH) holds an AI score of 39/100 (low). Investing in All Things Mobile Analytic Inc. Not financial advice.
How frequently does ATMH data refresh on this page?
ATMH's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ATMH's recent stock price performance?
All Things Mobile Analytic Inc. (ATMH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on integrating electronic data interfaces for healthcare providers. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ATMH overvalued or undervalued right now?
All Things Mobile Analytic Inc. (ATMH) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ATMH before investing?
Before investing in All Things Mobile Analytic Inc. (ATMH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data may not be fully audited or verified.
- AI analysis pending, which may provide further insights.